{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:14:53Z","timestamp":1757780093665,"version":"3.41.2"},"reference-count":27,"publisher":"FapUNIFESP (SciELO)","issue":"6","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"DOI":"10.1590\/1806-9282.20220992","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:26:18Z","timestamp":1684160778000},"source":"Crossref","is-referenced-by-count":1,"title":["Immunostaining of stromal CD56 cells in ovarian malignancies"],"prefix":"10.1590","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6926-558X","authenticated-orcid":false,"given":"Cid Almeida de","family":"Lima","sequence":"first","affiliation":[{"name":"Universidade Federal do Tri\u00e2ngulo Mineiro,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2693-8817","authenticated-orcid":false,"given":"Millena Prata","family":"Jammal","sequence":"additional","affiliation":[{"name":"Universidade Federal do Tri\u00e2ngulo Mineiro,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2241-5966","authenticated-orcid":false,"given":"Renata Margarida","family":"Etchebehere","sequence":"additional","affiliation":[{"name":"Universidade Federal do Tri\u00e2ngulo Mineiro,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4014-1345","authenticated-orcid":false,"given":"Eddie Fernando Candido","family":"Murta","sequence":"additional","affiliation":[{"name":"Universidade Federal do Tri\u00e2ngulo Mineiro,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6591-7619","authenticated-orcid":false,"given":"Rosekeila Sim\u00f5es","family":"Nomelini","sequence":"additional","affiliation":[{"name":"Universidade Federal do Tri\u00e2ngulo Mineiro,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2023]]},"reference":[{"journal-title":"Lyon (FR)","article-title":"GLOBOCAN 2020 - Cancer Today - International Agency for Research on Cancer (IARC)\/Global Initiative for Cancer Registry Development (GICR)","year":"2020","key":"ref1"},{"series-title":"Neoplasia maligna do corpo do \u00fatero e do ov\u00e1rio (taxas brutas)","key":"ref2"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel RL","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.trecan.2018.06.002","article-title":"The tumor microenvironment takes center stage in ovarian cancer metastasis","volume":"4","author":"Curtis M","year":"2018","journal-title":"Trends Cancer"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.3390\/ijms21093125","article-title":"The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: a focus on innate immunity cells as therapeutic effectors","volume":"21","author":"Baci D","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/01443615.2019.1633516","article-title":"Cytokines in peritoneal fluid of ovarian neoplasms","volume":"40","author":"Lima CA","year":"2020","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1186\/s12885-017-3585-x","article-title":"Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer","volume":"17","author":"James FR","year":"2017","journal-title":"BMC Cancer"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/08820139.2019.1637435","article-title":"Lymphocytes in peritumoral stroma: evaluation in epithelial ovarian neoplasms","volume":"49","author":"Lima CA","year":"2020","journal-title":"Immunol Invest"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4137\/CMO.S38333","article-title":"Cytokines and prognostic factors in epithelial ovarian cancer","volume":"10","author":"Jammal MP","year":"2016","journal-title":"Clin Med Insights Oncol"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/08820139.2017.1360342","article-title":"Serum IL-6 and IL-8 correlate with prognostic factors in ovarian cancer","volume":"46","author":"Sanguinete MMM","year":"2017","journal-title":"Immunol Invest"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4161\/cc.9.2.10430","article-title":"Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes","volume":"9","author":"Cubillos-Ruiz JR","year":"2010","journal-title":"Cell Cycle"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10238-018-0508-3","article-title":"TNF-R2 in tumor microenvironment as prognostic factor in epithelial ovarian cancer","volume":"18","author":"Nomelini RS","year":"2018","journal-title":"Clin Exp Med"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/08820139.2019.1691222","article-title":"IL-6 and IL-8 as prognostic factors in peritoneal fluid of ovarian cancer","volume":"49","author":"Rodrigues ISS","year":"2020","journal-title":"Immunol Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fimmu.2015.00500","article-title":"Real-time imaging of resident t cells in human lung and ovarian carcinomas reveals how different tumor microenvironments control T lymphocyte migration","volume":"6","author":"Bougherara H","year":"2015","journal-title":"Front Immunol"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"15621","DOI":"10.18632\/oncotarget.14919","article-title":"The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer","volume":"8","author":"Li J","year":"2017","journal-title":"Oncotarget"},{"issue":"13","key":"ref16","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1158\/1078-0432.CCR-14-3111","article-title":"Upregulation of periostin and reactive stroma is associated with primary chemoresistance and predicts clinical outcomes in epithelial ovarian cancer","volume":"21","author":"Ryner L","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer","volume":"22","author":"Kroeger DR","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3390\/cells9030635","article-title":"Three-dimensional cell culture based on magnetic fields to assemble low-grade ovarian carcinoma cell aggregates containing lymphocytes","volume":"9","author":"Nat\u00e2nia Souza-Ara\u00fajo C","year":"2020","journal-title":"Cells"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"616853","DOI":"10.3389\/fimmu.2021.616853","article-title":"Natural killer cells: potential biomarkers and therapeutic target in autoimmune diseases?","volume":"12","author":"Gianchecchi E","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"1843247","DOI":"10.1080\/2162402X.2020.1843247","article-title":"TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1\/TIGIT\/CD96 checkpoint molecules in ovarian cancer","volume":"9","author":"Maas RJ","year":"2020","journal-title":"Oncoimmunology"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3390\/cancers12071761","article-title":"Preclinical and clinical immunotherapeutic strategies in epithelial ovarian cancer","volume":"12","author":"Martinez A","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"78","key":"ref22","doi-asserted-by":"crossref","first-page":"34810","DOI":"10.18632\/oncotarget.26199","article-title":"Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients","volume":"9","author":"Hoogstad-van Evert JS","year":"2018","journal-title":"Oncotarget"},{"issue":"4","key":"ref23","first-page":"290","article-title":"Comparative study of various subpopulations of cytotoxic cells in blood and ascites from patients with ovarian carcinoma","volume":"19","author":"Lukesova S","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/PAS.0b013e3181609d59","article-title":"Expression of CD56 and WT1 in ovarian stroma and ovarian stromal tumors","volume":"32","author":"He H","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejcsup.2019.12.002","article-title":"Inflammation and immunity in ovarian cancer","volume":"15","author":"Salas-Benito D","year":"2020","journal-title":"EJC Suppl"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3390\/cells10071702","article-title":"Ovarian cancer-associated ascites have high proportions of cytokine-responsive CD56bright NK cells","volume":"10","author":"Tonetti CR","year":"2021","journal-title":"Cells"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002096","article-title":"Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis","volume":"9","author":"Gebremeskel S","year":"2021","journal-title":"J Immunother Cancer"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0104-42302023000600601&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:26:35Z","timestamp":1684160795000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302023000600601&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023]]}},"alternative-id":["S0104-42302023000600601"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.20220992","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"type":"electronic","value":"1806-9282"},{"type":"print","value":"0104-4230"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e20220992"}}